 Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > CARDIO-SPECT for Sale > TETRAKIS (2-METHOXYISOBUTYLISONITRILE) COPPER (I) TETRAFLUOROBORATE

TETRAKIS (2-METHOXYISOBUTYLISONITRILE) COPPER (I) TETRAFLUOROBORATE

1 Inquiries

Unit Price: Get Latest Price 

CAS No.:

103694-84-4

Port:

shanghai

Packaging:

as request

Price valid (until):

2024-10-29

Contact Supplier

 Chat Now

Hefei Heyu Chemical New Materials Co., Ltd

Company Type:

Trader

Location:

China

Qualification:

Main Products:

13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,Cyclohexylphenol,Methylene methanedisulfonate(MMDS)

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Basic Info

Product Name:

CARDIO-SPECT

Other Name:

COPPER(1+), TETRAKIS[1-(ISOCYANO-2-METHOXY-2-METHYLPROPANE)]-, (T-4)-, TETRAFLUOROBORATE(1-);COPPER TETRAMIBI TETRAFLUOROBORATE;CARDIO-SPECT;[CU(MIBI)4]BF4;TETRAKIS (2-METHOXY ISOBUTYL ISONITRILE) COPPER (I) TETRAFLUORBORATE;TETRAKIS (2-METHOXYISOBUTYLISONITRILE) COPPER (I) TETRAFLUOROBORATE;PROPANE, 1-ISOCYANO-2-METHOXY-2-METHYL-, COPPER COMPLEX;MIBI

CAS No.:

103694-84-4

Molecular Formula:

C24H44BCuF4N4O4

InChIKeys:

WJRFSUVOHUMYAO-UHFFFAOYSA-N

Molecular Weight:

602.98

Exact Mass:

602.269

UNII:

N6OU7HJ70P

Categories:

Bulk Drug Intermediates

Characteristics

PSA:

54.4

XLogP3:

3.54310

See More CARDIO-SPECT Properties 

Hazard Identification

Classification of the substance or mixture

Acute toxicity - Category 4, Oral

Acute toxicity - Category 4, Dermal

Skin irritation, Category 2

Eye irritation, Category 2

Acute toxicity - Category 4, Inhalation

Specific target organ toxicity â single exposure, Category 3

GHS label elements, including precautionary statements

Precautionary statement(s)
Pictogram(s)
Signal word	Warning
Hazard statement(s)	H302 Harmful if swallowed H312 Harmful in contact with skin H315 Causes skin irritation H319 Causes serious eye irritation H332 Harmful if inhaled H335 May cause respiratory irritation
Prevention	P264 Wash ... thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/... P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P271 Use only outdoors or in a well-ventilated area.
Response	P301+P317 IF SWALLOWED: Get medical help. P330 Rinse mouth. P302+P352 IF ON SKIN: Wash with plenty of water/... P317 Get medical help. P321 Specific treatment (see ... on this label). P362+P364 Take off contaminated clothing and wash it before reuse. P332+P317 If skin irritation occurs: Get medical help. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P319 Get medical help if you feel unwell.
Storage	P403+P233 Store in a well-ventilated place. Keep container tightly closed. P405 Store locked up.
Disposal	P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

Other hazards which do not result in classification

no data available

Handling and Storage

Precautions for safe handling

Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

Conditions for safe storage, including any incompatibilities

Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

See More CARDIO-SPECT Safety Data Sheet 

Seller Information

Business Type:
Trader

Main Products:
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,Cyclohexylphenol,Methylene methanedisulfonate(MMDS)

Location:
Room 1623,Building A, ZhongqiaoCenter,Goverment District,Hefei city,Anhui Province,China

Payment Terms:
TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance

Average lead Time:
7

Total Annual Revenue:
$1 million-$2.5 million

Total Employees:
5-10

Year of Establishment:
2019

Inquiry History

1 Inquiries

Country	Product	Purchase Quantity	Date Posted
India	Tetrakis (2-methoxyisobutylisonitrile) Copper (I) Tetrafluoroborate	10 G	Jan 6, 2025

Post an enquiry for this product